These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14364732)

  • 21. [Clinical studies on the coagulation-inhibiting activity of a new anticoagulant of the indandione series].
    STROBEL E
    Arzneimittelforschung; 1962 Jul; 12():718-20. PubMed ID: 13917816
    [No Abstract]   [Full Text] [Related]  

  • 22. PROPHYLACTIC ANTICOAGULANT THERAPY FOR CORONARY ARTERY DISEASE. A SEVEN-YEAR CONTROLLED STUDY.
    SEAMAN AJ; GRISWOLD HE; REAUME RB; RITZMAN LW
    JAMA; 1964 Jul; 189():183-7. PubMed ID: 14149998
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the phthalides and 1,3-indaniones. XXIX. Preparation and anticoagulation activity of 2-phenyl-1,3-indandiones substituted in the position 5 of the indandione and in the position 4' of the phenyl nucleus].
    Hrnciar P; Hrnciarová M; Kovalcík V
    Cesk Farm; 1968 Mar; 17(3):118-21. PubMed ID: 5666301
    [No Abstract]   [Full Text] [Related]  

  • 24. [EXPERIENCE WITH THE USE OF INDANDIONE ANTICOAGULANTS IN MYOCARDIAL INFARCT AND STENOCARDIA].
    ALUSCIN PM; SHAROVA IuA; DEMIDOVA NV
    Klin Med (Mosk); 1964 Jun; 42():83-5. PubMed ID: 14243265
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of nucleophilic and electrophilic substitutes on the anticoagulant action of various 2-phenyl-1, 3-indandione derivatives].
    CAVALLINI G; MILLA E; GRUMMELLI E; RAVENNA F
    Farmaco Sci; 1955; 10(10):710-32. PubMed ID: 13294151
    [No Abstract]   [Full Text] [Related]  

  • 26. A preliminary report on the clinical use of a new anticoagulant (miradon).
    BLAUSTEIN A
    N Y State J Med; 1958 Mar; 58(5):701-2. PubMed ID: 13517546
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental-clinical study of a new anticoagulant phenylindandione].
    BLEKSMIT ZD; KOTOVSHCHIKOVA MA; MARTYNOVA NV
    Vestn Khir Im I I Grek; 1958 Aug; 81(8):64-8. PubMed ID: 13593117
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect in man of a new indandione anticoagulant.
    FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC
    Proc Soc Exp Biol Med; 1952 Dec; 81(3):678-81. PubMed ID: 13037763
    [No Abstract]   [Full Text] [Related]  

  • 29. CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY.
    MICHAELS L
    Lancet; 1964 Oct; 2(7364):832-5. PubMed ID: 14197157
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulant resistance: an unusual case.
    Barnett DB; Hancock BW
    Br Med J; 1975 Mar; 1(5958):608-9. PubMed ID: 1125626
    [No Abstract]   [Full Text] [Related]  

  • 31. [Plan of anticoagulant therapy with 2-diphenylacetyl-1,3-indanedione in myocardial infarct].
    BOSISIO P
    Minerva Med; 1962 Jan; 53():58-61. PubMed ID: 13871585
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prolonged anticoagulant therapy of arterial and venous diseases with thrombo-embolic tendency].
    CASTIGLIONI G; TAMBORINI G
    Chir Ital; 1958 Jun; 10(3):233-59. PubMed ID: 13573547
    [No Abstract]   [Full Text] [Related]  

  • 33. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of phenylindanedione (danilone) in therapy of thromboembolic diseases].
    MILANES LOPEZ B; HERNANDEZ DIAZ DE ACEVEDO AL; TOLEDO VALDIVIA FB; NAVARRETTE G
    Rev Cubana Cardiol; 1954; 14(3-4):181-94. PubMed ID: 13195101
    [No Abstract]   [Full Text] [Related]  

  • 36. Simultaneous determination of seven anticoagulant rodenticides in agricultural products by gel permeation chromatography and liquid chromatography-tandem mass spectrometry.
    Saito-Shida S; Nemoto S; Matsuda R; Akiyama H
    J Environ Sci Health B; 2016 Nov; 51(11):801-8. PubMed ID: 27428755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of three anticoagulants in thrombo-embolic disease.
    NEILSON JM; MOLLISON AW
    Br Med J; 1957 May; 1(5029):1214-7. PubMed ID: 13426587
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effects of phenylindanedione on blood coagulation].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical study of phenylindanedione (danilone) in the treatment of thromboembolic diseases.
    MILANES LOPEZ B; HERNANDEZ AL; TOLEDO VALDIVIA F; NAVARRETE G
    Angiologia; 1954; 6(5):203-16. PubMed ID: 13218328
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of thrombosis with 2-phenylinandion].
    HAASE HW; BUSCHER G
    Zentralbl Chir; 1955; 80(31):1260-7. PubMed ID: 13274989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.